Predicting PD-L1 Status in Solid Tumors Using Transcriptomic Data and Artificial Intelligence Algorithms

Programmed death ligand-1 (PD-L1) immunohistochemistry (IHC) is routinely used to predict the clinical response to immune checkpoint inhibitors (ICIs); however, multiple assays and antibodies have been used. This study aimed to evaluate the potential of targeted transcriptome and artificial intellig...

Descripción completa

Detalles Bibliográficos
Autores principales: Charifa, Ahmad, Lam, Alfonso, Zhang, Hong, Ip, Andrew, Pecora, Andrew, Waintraub, Stanley, Graham, Deena, McNamara, Donna, Gutierrez, Martin, Jennis, Andrew, Sharma, Ipsa, Estella, Jeffrey, Ma, Wanlong, Goy, Andre, Albitar, Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2024
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695333/
http://dx.doi.org/10.1097/CJI.0000000000000489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695333/
http://dx.doi.org/10.1097/CJI.0000000000000489

Ejemplares similares